Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 5.1 Opinion of Gibson, Dunn & Crutcher LLP, Counsel of Cohbar, Inc
- 10.27 Exclusive License Agreement, Dated March 29, 2019, Between Morphogenesis, Inc. and H. Lee Moffitt Cancer and Research Institute, As Amended
- 10.28 Exclusive License Agreement, Dated April 23, 2021, Between Morphogenesis, Inc. and H. Lee Moffitt Cancer and Research Institute, As Amended
- 10.29 Restated and Amended Exclusive License Agreement, Dated September 7, 2022, Between Morphogene-sis, Inc. and West Virginia Research Corporation
- 10.30 Asset Purchase Agreement, Dated January 26, 2023, Between Tuhura Biopharma Inc. and Morphogenesis, Inc
- 23.1 Consent of Marcum LLP, Independent Registered Public Accounting Firm of Cohbar, Inc
- 23.2 Consent of Cherry Bekaert LLP, Independent Registered Public Accounting Firm of Morphogenesis, Inc
- Download Excel data file
- View Excel data file
Associated filings
- 13 Sep 23 EFFECT Notice of effectiveness
- 12 Sep 23 424B3 Prospectus supplement
- 12 Sep 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
10 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 30 Jun 23 S-4 Registration of securities issued in business combination transactions
CWBR similar filings
Filing view
External links
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of Cohbar, Inc. on Amendment No. 1 to Form S-4 [Registration No. 333-273101] of our report dated March 9, 2023 , with respect to our audits of the financial statements of Cohbar, Inc. as of December 31, 2022 and 2021, and for the years ended December 31, 2022 and 2021, which report appears in the Proxy Statement/Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Proxy statement/Prospectus.
/s/ Marcum llp
Marcum llp
New York, NY
August 10, 2023